Biogen Inc. buy Royal Bank of Canada
Start price
22.04.25
/
50%
€103.25
Target price
22.04.26
€195.75
Performance (%)
24.89%
Price
10:21
€128.95
Summary
This prediction is currently active. The prediction currently has a performance of 24.89%. This prediction currently runs until 22.04.26. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Biogen Inc. | 3.202% | 3.202% |
| iShares Core DAX® | 0.060% | 2.312% |
| iShares Nasdaq 100 | 0.854% | 2.162% |
| iShares Nikkei 225® | 2.174% | 6.737% |
| iShares S&P 500 | 0.746% | 1.835% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Biogen Inc. diskutieren
Biogen Inc. (NASDAQ: BIIB) had its price target raised by analysts at Royal Bank of Canada from $221.00 to $225.00. They now have an "outperform" rating on the stock.
Ratings data for BIIB provided by MarketBeat